Français
Movember
In the News
Prostate Cancer Canada Network
Our Team
Board of Directors
Halifax / Atlantic Region
Get Involved
PCC Atlantic News
Calgary / Western Region
Corp. Supporters
Careers at PCC
Testimonials
Financial Information
Your Donation In Action
Movember Funds
About Prostate Cancer
What is the prostate?
What is prostate cancer?
Signs and Symptoms of prostate cancer
Risk factors
Testing and Diagnosis
Glossary and Commonly Used Terms
Healthy Living Tips
Treatment
Active Surveillance
Radical Prostatectomy
Radiation Therapy
Hormone Therapy
Chemotherapy
New Treatments and Clinical Trials
Complemetary and Alternative Therapies
Facing Prostate Cancer
Questions to Ask your Doctor
About Research at PCC
Spotlight
Research Strategic Plan 2012-2015
Research Advisory Council
Publications by PCC-funded Researchers
What We're Funding
Innovation
Collaboration
Talented People
Funded Project Database
Review Process
Upcoming Programs
Information for Scientists
Announcements
2013 Movember Discovery Grants
2013 Rising Star
2013 Movember Team Grants
2012 Movember Pilot Grants
2012 Movember Clinician Scientist
Grants and Awards Guide
Frequently Asked Questions
Progress and Final Report
Policies for Research Grants and Awards
About Survivorship
What We Do
HERC
Current Programs
PCCN
PCCN Resources
Healthy Living Tips
Healthy Living Tips - Archive
Resources
Prostate Cancer News Archive
Survivorship Videos
Events
Pilgrimage for Progress
Rock the Road Raffle
Wake Up Call Breakfast
Father's Day Walk/Run
Prostate Cancer Awareness Week
PCCN Conference
Movember
Tied Together
Combines for Cures
Community Events
Volunteer
Volunteer Application
Volunteer Opportunities
Internships
Recognizing Volunteers
FAQs
Advocacy
Shop PCC
Supporting Retailers
GIVE NOW
Ways to Donate
Your Donation in Action
Summaries of Funded Research
Dr. Jeremy Squire
Dr. Fred Saad
Dr. Marek Los
Dr. Shana Kelley
Dr. Thomas Buckley
Dr. Kim Chi
Dr. Joseph L. Chin
Dr. Yves Fradet
Drs. Richard Choo and Laurence Klotz
Dr. Brad Nelson
Dr. Jim Xuan
Dr. Claude Labrie
For more information visit
www.movember.com
In The News
Media Advisory - Prostate Cancer Canada celebrates local Vancouver Hero
Vancouver, British Colombia, April 16 –– Prostate Cancer Canada will honour the late Jack Poole, former VANOC Board Chair and local businessman, with the Local Hero Award. Jack was a generous benefactor to the Vancouver General Hospital and UBC Hospital Foundation with gifts totalling $3 Million for “Jack the Robot”, a da Vinci S HD surgical system, and a $1 Million gift towards the Robert H. N. Ho Research Centre. His lead donation attracted a further $3.5 million in donations including $1.5 million from Jimmy Pattison. Together these donations enabled VGH to become the fourth Canadian hospital to employ robotic technology in surgery.
Media Advisory- Prostate Cancer Canada celebrates local Calgary Hero
Calgary, AB, April 10 –– Local Hero Dr. Jay Lee will be honoured on April 11th at the annual Wake Up Call Breakfast, hosted by Prostate Cancer Canada, in partnership with the Prostate Cancer Centre. Dr. Lee is being recognized for his extraordinary contribution to the fight against prostate cancer.
Click For Information Archive
In Search of a New Prostate Cancer Biomarker
Dr. Jeremy Squire (2003 and 2005 Research Grants)
Prostatic Intraepithelial Neoplasia (PIN)
is a non cancerous prostate condition but it has the potential to turn into cancer. High grade PIN, in particular, is a significant risk factor for prostate cancer. Dr. Squire’s research focuses on the links between high grade PIN and prostate cancer and he has found a promising new biomarker that may help diagnose the cases of PIN that are most likely to turn into prostate cancer. This biomarker is called a telomere. Telomeres are structures found on the ends of chromosomes that protect chromosomes from mutations and play an important role in deciding the number of times a cell can divide.
Every time an older cell divides it loses a tiny piece of DNA from the telomere. This process is called telomere attrition and it can make the telomeres too short to work properly, which causes the chromosomes to rearrange and result in genetic mutations (which in turn lead to high grade PIN and prostate cancer).
Squire’s study looked at a group of 68 men with high grade PIN (but not prostate cancer) and compared the lengths of their telomeres. The study found several significant links between short telomere length and long term diagnosis of prostate cancer – suggesting that telomere attrition in PIN is the basis of genetic mutations that cause prostate cancer.
In collaboration with local nanotechnology experts, Dr. Squire is now looking for quick and cost effective ways to measure telomere length during biopsies.
Twitter feed temporarily unavailable.
Follow Us On Twitter
GIVE NOW!
Ethics and Accountability
About Prostate Cancer
Prostate Cancer News
Careers
Prostate Cancer Canada
2 Lombard Street, 3rd Floor, Toronto
Ontario M5C 1M1, Canada
info@prostatecancer.ca
Telephone: 416-441-2131
Toll-free: 1-888-255-0333
Fax: 416-441-2325
Please note we cannot provide medical advice or endorse specific services, products, treatments or medical centres.
© 2011 - Prostate Cancer Canada - Charitable Registration Number: BN 89127 0944 RR0001
Design and Development
Inorbital